We support the next generation of scientists

Bernhard did his Ph.D. in bioprocess engineering at the BOKU in Vienna, where he was working on the implementation of the QbD/PAT principles into CHO cell culture processes. His thesis focused on how to properly control and monitor bioprocesses in regards to cell performance but also product quality attributes.
In his current position, he leads the “continuous integrated manufacturing” research and development team at Bilfinger Industrietechnik Salzburg. His team aims to develop and construct a fully automated and continuously driven End-to-End process train for bio-based products.

Igor has a position of associate professor at the University of Zagreb (Croatia) where he gives lectures on animal cell technology and tissue engineering. His regular working routine also involves the joy of applying for grants, writing reports, looking for collaborations, theses evaluation etc. He did his PhD about viral vaccine production in the University of Zagreb and soon after he worked as postdoctoral researcher on cell transfection and cell line development at NRC-Montreal and ULAVAL in Canada. He likes science popularization and tries locally to contribute to (young) people’s awareness on benefits and risks in the field of red biotechnology.

Nuša is currently a postdoctoral researcher at Novo Nordisk in the department for Screening & Bioassay Technology where she is generating cell-based assays for high-throughput microfluidic screening. She holds a Ph.D. in Industrial Biotechnology from Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, during which she was developing tools for predictable and improved recombinant gene expression in CHO cells for production of biopharmaceuticals. She is interested in gene editing, mammalian cell line engineering and synthetic biology. She is also passionate about communicating science to a wide variety of audiences and enjoys supporting the new generation of scientists in animal cell technology.

Paulo is in the Vector Operations team in Orchard Therapeutics, a cell & gene therapy company dedicated to rare diseases.
Before joining Orchard Therapeutics, Paulo worked as the vector process development team leader in Autolus, a company focused on CAR-T cell therapies to cure cancer. Paulo studied Microbiology at the Faculty of Medicine from Lisbon University, Portugal, and obtained his Ph.D. from ITQB/iBET, NOVA University of Lisbon, working on process development of viral vectors.

Ricardo currently works as a Patent Associate at CURELL SUÑOL SLP as Biotechnology specialist assessing clients in matters related to patent and design protection, preparation of patent and industrial design applications in Spain, the European Union and worldwide, analysing freedom to operate and patentability. He holds a Ph.D. in Biotechnology from Dublin City University, Ireland. During his doctoral studies at the National Institute for Cellular Biotechnology he worked on the development of novel miRNA-based genetic switches and novel approaches to engineer CHO cells.
He studied Biotechnology at the University of Barcelona and obtained a M.Sc. in Bioengineering from IQS-University Ramon Lull, Barcelona, Spain.